M Hasib Sidiqi

1.1k total citations
56 papers, 561 citations indexed

About

M Hasib Sidiqi is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, M Hasib Sidiqi has authored 56 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 36 papers in Hematology and 20 papers in Genetics. Recurrent topics in M Hasib Sidiqi's work include Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Multiple Myeloma Research and Treatments (25 papers) and Chronic Myeloid Leukemia Treatments (11 papers). M Hasib Sidiqi is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Multiple Myeloma Research and Treatments (25 papers) and Chronic Myeloid Leukemia Treatments (11 papers). M Hasib Sidiqi collaborates with scholars based in United States, Australia and Saudi Arabia. M Hasib Sidiqi's co-authors include Morie A. Gertz, Rahma Warsame, Angela Dispenzieri, David Dingli, Martha Q. Lacy, Shaji Kumar, Taxiarchis Kourelis, Wilson I. Gonsalves, Francis K. Buadi and Prashant Kapoor and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

M Hasib Sidiqi

51 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Hasib Sidiqi United States 13 454 225 161 134 104 56 561
Hugh J. B. Goodman United Kingdom 12 666 1.5× 139 0.6× 183 1.1× 172 1.3× 158 1.5× 22 758
Gabriele Sarais Italy 7 466 1.0× 88 0.4× 129 0.8× 119 0.9× 94 0.9× 7 505
Stephen R. Zeldenrust United States 10 417 0.9× 302 1.3× 201 1.2× 152 1.1× 55 0.5× 16 573
Steve R. Zeldenrust United States 7 949 2.1× 196 0.9× 265 1.6× 239 1.8× 188 1.8× 9 1000
Irini Xilouri Greece 7 238 0.5× 208 0.9× 119 0.7× 123 0.9× 37 0.4× 13 375
Xianghua Huang China 10 180 0.4× 67 0.3× 67 0.4× 51 0.4× 49 0.5× 32 309
DV Faller United States 6 235 0.5× 163 0.7× 167 1.0× 62 0.5× 71 0.7× 7 431
Abdullah Hacıhanefioğlu Türkiye 11 124 0.3× 222 1.0× 55 0.3× 90 0.7× 28 0.3× 30 424
Ernesto Anesi Italy 9 375 0.8× 51 0.2× 87 0.5× 74 0.6× 54 0.5× 10 423
S. Madhoo United Kingdom 9 464 1.0× 85 0.4× 25 0.2× 65 0.5× 58 0.6× 17 577

Countries citing papers authored by M Hasib Sidiqi

Since Specialization
Citations

This map shows the geographic impact of M Hasib Sidiqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hasib Sidiqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hasib Sidiqi more than expected).

Fields of papers citing papers by M Hasib Sidiqi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Hasib Sidiqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hasib Sidiqi. The network helps show where M Hasib Sidiqi may publish in the future.

Co-authorship network of co-authors of M Hasib Sidiqi

This figure shows the co-authorship network connecting the top 25 collaborators of M Hasib Sidiqi. A scholar is included among the top collaborators of M Hasib Sidiqi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Hasib Sidiqi. M Hasib Sidiqi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Sarah E., et al.. (2024). Imaging flow cytometric detection of del(17p) in bone marrow and circulating plasma cells in multiple myeloma. International Journal of Laboratory Hematology. 46(3). 495–502. 1 indexed citations
2.
Gibbons, A.J., N. Anderson, Fiona Kwok, et al.. (2023). Identifying Early Suboptimal Hematological Response in Patients with AL Amyloidosis Treated with Bortezomib-Based Chemotherapy. Blood. 142(Supplement 1). 2030–2030. 1 indexed citations
3.
Erber, Wendy N., et al.. (2023). “Double Hit” Myeloma: Detection By FISH and Flow Cytometry in Circulating Myeloma Plasma Cells. Blood. 142(Supplement 1). 1962–1962.
4.
Saleh, Abdullah S. Al, M Hasib Sidiqi, Angela Dispenzieri, et al.. (2022). Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation. Blood Cancer Journal. 12(4). 59–59. 2 indexed citations
5.
Sidiqi, M Hasib, Abdullah S. Al Saleh, Shaji Kumar, et al.. (2021). Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials. American Journal of Hematology. 96(9). 1131–1136. 24 indexed citations
6.
Sidiqi, M Hasib, et al.. (2021). Immune‐mediated neuromuscular complications of graft‐versus‐host disease. Muscle & Nerve. 63(6). 852–860. 12 indexed citations
7.
Sidana, Surbhi, Eli Muchtar, M Hasib Sidiqi, et al.. (2020). Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis. American Journal of Hematology. 95(5). 497–502. 32 indexed citations
8.
Vaxman, Iuliana, M Hasib Sidiqi, Abdullah S. Al Saleh, et al.. (2020). Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis. Bone Marrow Transplantation. 56(4). 928–935. 5 indexed citations
9.
Saleh, Abdullah S. Al, Iuliana Vaxman, Alissa Visram, et al.. (2020). Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation. Bone Marrow Transplantation. 56(1). 274–277. 2 indexed citations
10.
Saleh, Abdullah S. Al, M Hasib Sidiqi, Eli Muchtar, et al.. (2019). Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved. Biology of Blood and Marrow Transplantation. 25(8). 1520–1525. 7 indexed citations
11.
Saleh, Abdullah S. Al, M Hasib Sidiqi, Surbhi Sidana, et al.. (2019). Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis. American Journal of Hematology. 94(10). 1066–1071. 13 indexed citations
12.
Sidana, Surbhi, M Hasib Sidiqi, Angela Dispenzieri, et al.. (2019). Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis. American Journal of Hematology. 94(9). 1020–1026. 31 indexed citations
13.
Saleh, Abdullah S. Al, M Hasib Sidiqi, Angela Dispenzieri, et al.. (2019). Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients. American Journal of Hematology. 95(1). 4–9. 11 indexed citations
14.
Saleh, Abdullah S. Al, M Hasib Sidiqi, Morie A. Gertz, et al.. (2019). Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma. American Journal of Hematology. 95(1). E8–E10. 12 indexed citations
15.
Sidiqi, M Hasib, et al.. (2019). The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors. Acta Haematologica. 143(2). 118–123. 19 indexed citations
16.
Sidiqi, M Hasib, Abdullah S. Al Saleh, Nelson Leung, et al.. (2019). PF625 VENETOCLAX FOR THE TREATMENT OF TRANSLOCATION (11; 14) AL AMYLOIDOSIS. HemaSphere. 3(S1). 265–266. 1 indexed citations
17.
Sidiqi, M Hasib, Francis K. Buadi, Angela Dispenzieri, et al.. (2018). Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis. Biology of Blood and Marrow Transplantation. 25(3). e108–e111. 17 indexed citations
18.
Vaxman, Iuliana, M Hasib Sidiqi, & Morie A. Gertz. (2018). Venetoclax for the treatment of multiple myeloma. Expert Review of Hematology. 11(12). 915–920. 26 indexed citations
19.
Sidiqi, M Hasib, Mohammed A. Aljama, Dragan Jevremović, et al.. (2018). Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis. Biology of Blood and Marrow Transplantation. 24(11). 2360–2364. 9 indexed citations
20.
Richards, Stephen B., et al.. (2016). Determinants of 6-month survival of critically ill patients with an active hematologic malignancy. Journal of Critical Care. 36. 252–258. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugh J. B. Goodman Breakdown of academic impact, for papers by Gabriele Sarais Breakdown of academic impact, for papers by Stephen R. Zeldenrust Breakdown of academic impact, for papers by Steve R. Zeldenrust Breakdown of academic impact, for papers by Irini Xilouri Breakdown of academic impact, for papers by Xianghua Huang Breakdown of academic impact, for papers by DV Faller Breakdown of academic impact, for papers by Abdullah Hacıhanefioğlu Breakdown of academic impact, for papers by Ernesto Anesi Breakdown of academic impact, for papers by S. Madhoo
Rankless by CCL
2026